Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
January-2018 Volume 15 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2018 Volume 15 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

The inhibitory roles of Ihh downregulation on chondrocyte growth and differentiation

Expression of Concern in: /10.3892/etm.2025.12946
  • Authors:
    • Ang Deng
    • Hongqi Zhang
    • Minyu Hu
    • Shaohua Liu
    • Yuxiang Wang
    • Qile Gao
    • Chaofeng Guo
  • View Affiliations / Copyright

    Affiliations: Department of Spine Surgery, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China, Department of Nutrition and Food Hygiene, School of Public Health, Central South University, Changsha, Hunan 410078, P.R. China
    Copyright: © Deng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 789-794
    |
    Published online on: November 7, 2017
       https://doi.org/10.3892/etm.2017.5458
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The proliferative rate of chondrocytes affects bone elongation. Chondrocyte hypertrophy is required for endochondral bone formation as chondrocytes secrete factors required for osteoblast differentiation and maturation. Previous studies have demonstrated that the Indian hedgehog (Ihh) signaling pathway is a key regulator of skeletal development and homeostasis. The aim of the present study was to investigate the function of Ihh in chondrocyte proliferation and differentiation, as well as the underlying mechanisms. Ihh was knocked down in mouse chondrocyte cells using short hairpin RNA. Chondrocyte apoptosis and cell cycle arrest were assessed using flow cytometry and the results indicated that knockdown of Ihh significantly inhibited cell growth (P<0.05) and increased apoptosis (P<0.001) compared with negative control cells. Downregulation of Ihh also resulted in cell cycle arrest at G1 to S phase in chondrocytes. It was also observed that knockdown of Ihh decreased alkaline phosphatase activity and mineral deposition of chondrocytes. The inhibitory roles of Ihh downregulation on chondrocyte growth and differentiation may be associated with the transforming growth factor‑β/mothers against decapentaplegic and osteoprotegerin/receptor activator of nuclear factor κB ligand signaling pathway. The results of the present study suggest that chondrocyte‑derived Ihh is essential for maintaining bone growth plates and that manipulation of Ihh expression or its signaling components may be a novel therapeutic technique for the treatment of skeletal diseases, including achondroplasia.

Introduction

Bone formation in the developing embryo is governed by intramembranous and endochondral ossification initiating from mesenchymal condensations, in which mesenchymal progenitor cells differentiate (1). During endochondral ossification, mesenchymal progenitors differentiate into chondrocytes to form the cartilage template of the bone, which is required for bone elongation. Chondrocyte hypertrophy is required for endochondral bone formation; elongated chondrocytes exit the cell cycle to become prehypertrophic chondrocytes prior to terminally differentiating to form hypertrophic chondrocytes (2). These chondrocytes subsequently secrete factors required for osteoblast differentiation and maturation (3).

It has previously been reported that the Indian hedgehog (Ihh) signaling pathway is a key regulator of skeletal development and homeostasis (4) and that Ihh signaling must be enhanced to increase bone formation (5). In a previous study, overexpression of Ihh ameliorated short stature homeobox 2 (shox2) overexpression-associated reduction of extracellular matrix components; however, it did not inhibit the increase in matrix metalloproteinase (MMP)9 and MMP13, or apoptosis in the temporomandibular joint, which suggests that overexpression of Ihh only partially inhibits shox2 overexpression-associated congenital dysplasia of the temporomandibular joint (6). Dysregulation of Ihh signaling results in multiple bone diseases, including progressive osseous heteroplasia (7). Treatment with an Ihh signaling inhibitor has been reported to reduce the occurrence of chondroma-like lesions, including enchondromas and osteochondromas, adjacent to disordered growth plates in fibroblast growth factor receptor 3-deficient mice (8). Ihh deletion also induces symphalangism, characterized by initial cartilaginous fusion preventing epiphyseal growth plate formation, resulting in abnormal directionality of chondrocyte differentiation in mutant mice (9). Ihh signaling serves an important role in the mineralization process of fibrocartilaginous entheses (10). Inhibiting Hh signaling reduces mineralized fibrocartilage, leading to less collagen embedded within mineralized tissue (11). Understanding the signaling mechanisms and functions of Ihh signaling in bone development may provide important insights into bone disease prevention and therapeutics.

In the present study, Ihh was knocked down in chondrocytes using short hairpin (sh)RNA to investigate the function of Ihh signaling in chondrocyte proliferation and differentiation. The present study also aimed to explore the potential mechanism by which Ihh induces chondrocyte apoptosis and cell cycle arrest.

Materials and methods

Cell line and cell transfection

Mouse chondrocyte cells (CP-M087) were purchased from Procell Life Science & Technology Co., Ltd. (Wuhan, China). Cells were grown routinely in Dulbecco's modified Eagle's medium/F-12 medium (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.) and cultured for 24 h before refreshing the medium in a 37°C humidified atmosphere containing 5% CO2. Knockdown of Ihh in chondrocyte cells was achieved by transfection with 5 µl (109 U) lentivirus containing Ihh shRNA (Ihh-shRNA; Shanghai GenePharma Co., Ltd., Shanghai, China) for 48 h using Lipofectamine 3000 (Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. Cells transfected with empty lentivirus were used as a negative control (NC), and untreated cells were used as blank control. Cells (5×105 cells/ml) were seeded in 6-well clusters (1 ml) or 96-well plates (0.2 ml) and transfected for 48 h. Transfected cells were used in further assays or RNA/protein extraction.

RNA extraction and reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

Total RNA was extracted from cells using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, Inc.) was used to reverse transcribe the mRNA to cDNA according to the manufacturer's protocol. Briefly, 0.5 ng of the template RNA, 1 µl oligo(dT)18 primer and 12 µl RNase free water were mixed, and incubated at 65°C for 5 min, then cooled down on ice. The mixture was added to Reaction Buffer (4 µl), RiboLock RNase inhibitor (1 µl), 10 mM dNTP mix (2 µl) and RevertAid Reverse Transcriptase (1 µl), and incubated at 42°C for 1 h. Finally, the mixture was heated to 70°C for 5 min to obtain the cDNA. Ihh, parathyroid hormone-related protein (PTHrP), transforming growth factor (TGF)-β, osteocalcin (OCN), runt-related transcription factor 2 (Runx2), osteoprotegerin (OPG), mothers against decapentaplegic homolog 2 (Smad2), Smad3, collagen type X α1 chain (COL10A) and receptor activator of nuclear factor-κB ligand (RANKL) mRNA expression was measured using SYBR Fast qPCR Mix (cat. no. RR430A; Takara Biotechnology Co., Ltd., Dalian, China) under the following conditions: 95°C for 30 sec, followed by 40 cycles of 95°C for 5 sec and 60°C for 10 sec, and then for melting curves (one cycle of 95°C for 5 sec and 60°C for 60 sec, followed by cooling to 50°C in 30 sec) β-actin was used as an endogenous control. Primers sequences used for qPCR were as follows: Ihh, forward 5′-CTCAGCCTGCTCTCACTACG-3′ and reverse 5′-AAGCACATCCAACCCACCTC-3′; PTHrP, forward 5′-CGAGGTTCAAAGGTTTGCCTC-3′ and reverse 5′-GGCCAGAGAAGCCTGTTACC-3′; TGF-β, forward 5′-AGGGCTACCATGCCAACTTC-3′ and reverse 5′-TGACACAGAGATCCGCAGTC-3′; OCN, forward 5′-TCCTTTGGGGTTTGGCCTAC-3′ and reverse 5′-CTTGGACACAAAGGCTGCAC-3′; RUNX2, forward 5′-CGCCTCACAAACAACCACAG-3′ and reverse 5′-TCACTGTGCTGAAGAGGCTG-3′; OPG, forward 5′-CTGGAACCCCAGAGCGAAAT-3′ and reverse 5′-GCGTTTACTTTGGTGCCAGG-3′; Smad2, forward 5′-GTTCCTTTCCTCCTCCGCTC-3′ and reverse 5′-AGTCTCTTCACAACTGGCGG-3′; Smad3, forward 5′-TTCACTGGTGCTGGGGTTAG-3′ and reverse 5′-GGTAGGGATTCACGCAGACC-3′; COL10A, forward 5′-CTCCCAGCACGCAGAATC-3′ and reverse: 5′-TTCCCTACAGCTGATGGTCC-3′; RANKL, forward 5′-GGAGTTGGCCGCAGACAAGA-3′ and reverse 5′-TGATGTGCTGTGATCCAACGA-3′; and β-actin, forward 5′-GCAGGAGTATGACGAGTCCG-3′ and reverse 5′-AACAACGCATCTCATATTTGGAA-3′. Data were processed using the 2−ΔΔCq method (12).

Cell Counting Kit-8 (CCK-8) cell proliferation assay

Cell proliferation rates were measured using CCK-8 (Beyotime Institute of Biotechnology, Haimen, China). A total of 0.5×104 cells were seeded in 96-well plates for 24 h, transfected with the indicated lentivirus, and further incubated for 24, 48 and 72 h at 37°C, respectively. A total of 10 µl CCK-8 reagents were added to each well at 1 h prior to the endpoint of incubation (23, 47 and 71 h). The optical density of each well was subsequently determined using a microplate reader at a wavelength of 490 nm.

Flow cytometric analysis of apoptosis with Annexin-V/propidium iodide (PI) double staining

An Annexin V Apoptosis Detection kit (Thermo Fisher Scientific, Inc.) was used to assess apoptosis. Following incubation for 24, 48 or 72 h at 37°C, the cells were trypsinized for 2 min at 37°C, collected by centrifugation (960 × g) for 5 min at room temperature and resuspended in 2 ml medium. Approximately 2×105 cells were harvested, washed twice with cold PBS and resuspended in 500 µl binding buffer provided in the kit. A total of 10 µl Annexin V-fluorescein isothiocyanate and 10 µl PI was added to the solution and mixed well. Following incubation for 15 min at 37°C, cells were analyzed using a flow cytometer (BD Biosciences, San Jose, CA, USA).

Cell cycle analysis assay

Cell cycle analysis was determined by flow cytometry using a Cell Cycle and Apoptosis Analysis kit (cat no. C1052, Beyotime Institute of Biotechnology) and analyzed the data using Flowjo (7.6 version; Flowjo LLC, Ashland, OR, USA). Briefly, ~1×104 cells were seeded in each well of a 6-well plate. Following 48 h transfection with Ihh-shRNA or empty lentivirus, cells were harvested and fixed in 70% ice-cold ethanol for 24 h, followed by staining with PI for 10 min at room temperature. The different phases of the cell cycle were analyzed using a FACSCalibur flow cytometer (BD Biosciences).

Alkaline phosphatase (ALP) assay

Alkaline Phosphatase Assay Kit (cat no. P0321, Beyotime Institute of Biotechnology) was used to detect ALP activity according to the manufacturer's protocol. Black cobaltous sulfide staining indicated a positive signal. Cells were counterstained with nuclear fast red for 5 min at room temperature to label the nucleus and cytoplasm of cells. Images were captured using an inverted microscope (magnification, ×100; Nikon Eclipse TC 100; Nikon Corporation, Tokyo, Japan).

Determination of mineralization using von Kossa staining

Von Kossa staining (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) was used to determine the extent of minerals deposited on chondrocyte cells. Silver nitrate solution was added to the cells and the plate was exposed to ultraviolet light for 30 min. Cells were subsequently washed with PBS and the reaction was stopped with the addition of 500 µl of 5% sodium thiosulfate (Sigma-Aldrich; Merck KGaA). The positive mineral depositions were stained in black. Cells were counterstained with nuclear fast red for 5 min at room temperature to label the nucleus and cytoplasm. Images were captured using an inverted microscope (magnification, ×100; Nikon Eclipse TC 100; Nikon Corporation).

Western blot analysis

Immunoblotting was performed to detect the expression of Ihh, PTHrP, TGF-β, OCN, Runx2, OPG, Smad2, Smad3, COL10A and RANKL in chondrocyte cells. Cultured or transfected cells were lysed in radioimmunoprecipitation assay buffer (Wuhan Boster Biological Technology, Ltd., Wuhan, China) with 1% phenylmethylsulfonyl fluoride. The concentration of protein was determined using the BCA Protein Assay kit (cat no. P0011; Beyotime Institute of Biotechnology, Haimen, China) according to the manufacturer's protocol. A total of 60 µg/lane of proteins were separated by 12% SDS-PAGE and transferred onto polyvinyl difluoride membranes. The membranes were blocked in non-fat milk for 1 h at 37°C. Membranes were incubated at 4°C overnight with the following primary antibodies: Anti-Ihh, (cat. no. SAB1403965; dilution, 1:1,000); anti-PTHrP (cat. no. SAB5300029; dilution, 1:1,000); anti-TGF-β (cat. no. SAB4502958; dilution, 1:2,000); anti-OCN (cat. no. SAB1306277; dilution, 1:2,000; all from Sigma Aldrich; Merck KGaA); anti-RUNX2 (cat. no. 12556; dilution, 1:1,000); anti-OPG (cat. no. 4816; dilution, 1:1,000); anti-Smad2 (cat. no. 5339; dilution, 1:1,000), anti-Smad3 (cat. no. 9523; dilution, 1:1,000; all from Cell Signaling Technology, Inc., Danvers, MA, USA); anti-COL10A (cat. no. ab58632; dilution, 1:1,000); anti-RANKL (cat. no. ab9957; dilution, 1:1,000) and anti-GAPDH (cat. no. ab9485; dilution, 1:3,000; all from Abcam, Cambridge, UK). The blots were subsequently incubated with goat anti-rabbit IgG (cat. no. ab7090) and goat anti-mouse (cat. no. ab97040; both 1:5,000; Abcam) horseradish peroxidase-conjugated secondary antibodies for 1 h at 37°C. Signals were visualized using enhanced chemiluminescence substrates (EMD Millipore, Billerica, MA, USA). The densitometry of bands was analyzed using Quantity One software (version 4.6.9; Bio-Rad Laboratories, Inc., Hercules, CA, USA). GAPDH was used as an endogenous protein for normalization.

Statistical analysis

All data are expressed as the mean ± standard deviation of three independent experiments. Statistical analyses were performed using SPSS v. 17.0 (SPSS, Inc., Chicago, IL, USA). Differences between groups were analyzed using Student's t-test or one-way analysis of variance with Tukey's post hoc test dependent on the conditions. P<0.05 was considered to indicate a statistically significant difference.

Results

Effects of Ihh on chondrocyte cell proliferation, apoptosis and cell cycle

To investigate the biological role of Ihh in chondrocyte cell growth, chondrocytes transfected with Ihh shRNA were used in the present study. The results of RT-qPCR revealed that Ihh expression was significantly reduced in transfected cells compared with NC cells (P<0.001; Fig. 1A). Ihh downregulation significantly inhibited cell growth (P<0.05; Fig. 1B) and significantly increased the apoptosis rate compared with the NC group (P<0.001; Fig. 2A). In addition, Ihh knockdown significantly reduced the percentage of cells in S phase (P<0.05) and increased the percentage of cells in G1 phase compared with the NC group (P<0.01), indicating cell cycle arrest at G1 to S phase (Fig. 2B).

Figure 1.

(A) Reverse transcription-quantitative polymerase chain reaction was used to detect Ihh expression and (B) Cell Counting Kit-8 was used to assess cell viability in chondrocytes following transfection with Ihh shRNA or empty lentivirus. *P<0.05 and ***P<0.001 vs. NC. Ihh, Indian hedgehog; shRNA, short hairpin RNA; NC, negative control; OD, optical density.

Figure 2.

Chondrocytes were transfected with Ihh shRNA or empty lentivirus. (A) Apoptosis and (B) cell cycle distribution were assessed using flow cytometry. *P<0.05, **P<0.01 and ***P<0.001 vs. NC. Ihh, Indian hedgehog; shRNA, short hairpin RNA; NC, negative control.

Effects of Ihh on chondrocyte cell differentiation

ALP is an enzyme that is required for bone mineralization (13). ALP activity was assessed in the present study and was markedly decreased in Ihh knockdown cells compared with the NC group (Fig. 3A). The calcification and mineralization of bone matrix are essential for the strength and rigidity of the spinal skeletal system (14). To estimate mineralization and calcification, von Kossa staining was performed following Ihh knockdown. Representative images of von Kossa staining were obtained by bright field microscopy (Fig. 3B). Compared with the NC cells, mineral deposition was markedly decreased in the Ihh-shRNA group.

Figure 3.

Alkaline phosphatase (ALP) assay was used to determine alkaline phosphatase activity in chondrocytes. (A) Alkaline phosphatase activity was markedly decreased in chondrocytes transfected with Ihhsh RNA compared with the NC group. Magnification, ×100. (B) Von Kossa staining was used to determine the extent of mineral deposition (black staining) in chondrocyte cells. Deposition was markedly decreased in cells transfected with Ihh-shRNA compared with the NC group. Ihh, Indian hedgehog; shRNA, short hairpin RNA; NC, negative control.

Effects of Ihh on TGF-β/Smads and OPG/RANKL signaling

The effects of Ihh on TGF-β/Smads and OPG/RANKL signaling were also investigated. The mRNA expression of COL10A, RANKL, Samd2 and Smad3 was significantly upregulated in the Ihh-shRNA group compared with the NC cells (P<0.001; Fig. 4), whereas the levels of OCN, OPG, PTHrP, Runx2 and TGF-β were significantly downregulated in the Ihh-shRNA compared with the NC group (P<0.001; Fig. 4). Protein expression of these genes was further assessed by western blot analysis (Fig. 5). The protein expression of COL10A, RANKL, Samd2 and Smad3 were upregulated, whereas levels of OCN, OPG, PTHrP, Runx2 and TGF-β were significantly downregulated in Ihh knockdown cells compared with the NC group (P<0.05; Fig. 5). These findings suggest that the inhibitory effects of Ihh knockdown on bone differentiation and generation are achieved via the TGF-β/Smads and OPG/RANKL signaling pathway.

Figure 4.

Reverse transcription-quantitative polymerase chain reaction was used to detect the mRNA expression of COL10A, RANKL, Smad2, Smad3, OCN, OPG, PTHrP, Runx2 and TGF-β in chondrocytes following transfection with Ihh shRNA or empty lentivirus. ***P<0.001 vs. NC. COL10A, collagen type X α1 chain; RANKL, receptor activator of nuclear factor-κB ligand; Smad, mothers against decapentaplegic; OCN, osteocalcin; OPG, osteoprotegerin; PTHrP, parathyroid hormone-related protein; Runx2, runt-related transcription factor 2; TGF, transforming growth factor; Ihh, Indian hedgehog; shRNA, short hairpin RNA; NC, negative control.

Figure 5.

Western blot analysis was used to detect the protein expression of COL10A, RANKL, Smad2, Smad3, OCN, OPG, PTHrP, Runx2 and TGF-β in chondrocytes following transfection with Ihh shRNA or empty lentivirus. *P<0.05 vs. NC. COL10A, collagen type X α1 chain; RANKL, receptor activator of nuclear factor-κB ligand; Smad, mothers against decapentaplegic homolog; OCN, osteocalcin; OPG, osteoprotegerin; PTHrP, parathyroid hormone-related protein; Runx2, runt-related transcription factor 2; TGF, transforming growth factor; Ihh, Indian hedgehog; shRNA, short hairpin RNA; NC, negative control.

Discussion

In the present study, Ihh knockdown was demonstrated to significantly inhibit cell growth and increase the apoptosis rate compared with NC cells. Downregulation of Ihh resulted in cell cycle arrest at G1 to S phase in chondrocytes. In addition, Ihh knockdown decreased the ALP activity and mineral deposition of chondrocytes. These results suggest that the inhibitory roles of Ihh downregulation on chondrocyte growth and differentiation may be associated with the TGF-β/Smads and OPG/RANKL signaling pathways.

Ihh signaling is essential for chondrocyte differentiation and endochondral ossification (15). Deletion of Ihh in postnatal chondrocytes in a temporal/spatial-specific manner results in the loss of ectopic hypertrophic chondrocyte formation in the growth plate (16). In a previous study, mutant mice with Ihh deletion exhibited a continuous loss of trabecular bone over time, which indicates that postnatal chondrocyte-derived Ihh is essential for skeletal growth, maintaining the growth plate and sustaining trabecular bone growth (16). A previous report demonstrated that treating chondrogenic cells with an Ihh inhibitor inhibited chondrocyte differentiation and secondary ossification center formation (17). Furthermore, Gualeni et al (18) previously demonstrated that diastrophic dysplasia mouse proteoglycan undersulfation resulted in reduced chondrocyte proliferation in the proliferative zone via the Ihh pathway, contributing to reduced long bone growth. Ihh expression has been reported to be significantly increased in humans with the modic degeneration I and II groups and is positively correlated with the severity of degeneration (19). Overexpression of Ihh signaling promotes abnormal chondrocyte differentiation in endochondral ossification and enhances bone formation in posterior longitudinal ligaments (20). Ihh is synthesized by chondrocytes and is required for the synthesis of PTHrP (21). Ihh acts with PTHrP in a negative feedback loop to regulate early chondrocyte differentiation and hypertrophic differentiation (22). Blocking Ihh signaling with cyclopamine has been reported to delay chondrocyte hypertrophy in PTHrP knockout embryos, whereas upregulating Ihh signaling in the postnatal cartilage led to accelerated chondrocyte hypertrophy during secondary ossification, indicating that Ihh signaling promotes chondrocyte hypertrophy independently of PTHrP, which may be mediated by Wnt/β-catenin signaling (23,24). As chondrocytes go through a program of proliferation and subsequent differentiation into hypertrophic chondrocytes, PTHrP maintains chondrocyte proliferation and delays their further differentiation (25). The differentiation-delaying action of PTHrP is mediated by suppressing the synthesis of Runx2, which is a transcription factor integral to osteoblast differentiation (26). In the absence of Ihh, the osteoblast fails to activate the expression of Runx2 (27). However, forced expression of Runx2 in the skeletogenic cells restores bone formation in the Runx2-null embryo, whereas it does not in the Ihh-null embryo; this suggests that Ihh-induced osteoblast differentiation requires additional effectors (27).

The results of the present study demonstrate that the mRNA and protein expression of hypertrophic markers, including COL10A, RANKL, Smad2 and Smad3, are upregulated in chondrocytes following Ihh knockdown, whereas levels of OCN, OPG, PTHrP Runx2 and TGF-β are significantly reduced. Previous studies have reported that multiple signaling pathways, including Wnt/β-catenin and TGF-β/Smad pathways, are able to regulate chondrocyte hypertrophy (28). The Smad2/3 pathway is directly activated by TGF-β, which leads to inhibited hypertrophy (29). TGF-β activation of Smad3 also inhibits Runx2 via epigenetic regulation (30). Glioma-associated oncogene-Krüppel family members (Gli) 1 and 2, which are Ihh downstream transcription factors, increase COL10A activity and Runx2 promotes COL10A1 expression via interacting with Ihh (31). Furthermore, Gli1 and Gli2 act in a complex with Runx2/Smad to induce chondrocyte differentiation (30), suggesting that Ihh signaling may be an important factor for early chondrocyte differentiation and the maturation and calcification of chondrocytes.

In conclusion, knockdown of Ihh suppresses chondrocyte growth and differentiation and this effect may be associated with the TGF-β/Smad and OPG/RANKL signaling pathways. These results suggest that chondrocyte-derived Ihh is essential for maintaining the growth plate and that manipulating Ihh expression or its signaling components may be a novel effective treatment for achondroplasia and other skeletal diseases.

Acknowledgements

The present study was supported by the Natural Science Foundation of Hunan Province (grant no. 2016JJ3160) and the National Natural Science Foundation of China (grant no. 81472145).

References

1 

Wang T, Zhang X and Bikle DD: Osteogenic differentiation of periosteal cells during fracture healing. J Cell Physiol. 232:913–921. 2017. View Article : Google Scholar : PubMed/NCBI

2 

Komori T: Cell death in chondrocytes, osteoblasts, and osteocytes. Int J Mol Sci. 17:pii: E20452016. View Article : Google Scholar

3 

Xu J, Li Z, Hou Y and Fang W: Potential mechanisms underlying the Runx2 induced osteogenesis of bone marrow mesenchymal stem cells. Am J Transl Res. 7:2527–2535. 2015.PubMed/NCBI

4 

Day TF and Yang Y: Wnt and hedgehog signaling pathways in bone development. J Bone Joint Surg Am. 90 Suppl 1:S19–S24. 2008. View Article : Google Scholar

5 

Cai H and Liu A: Spop promotes skeletal development and homeostasis by positively regulating Ihh signaling. Proc Natl Acad Sci USA. 113:pp. 14751–14756. 2016; View Article : Google Scholar : PubMed/NCBI

6 

Li X, Liang W, Ye H, Weng X, Liu F, Lin P and Liu X: Overexpression of Indian hedgehog partially rescues short stature homeobox 2-overexpression-associated congenital dysplasia of the temporomandibular joint in mice. Mol Med Rep. 12:4157–4164. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Yang J, Andre P, Ye L and Yang YZ: The hedgehog signalling pathway in bone formation. Int J Oral Sci. 7:73–79. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Zhou S, Xie Y, Tang J, Huang J, Huang Q, Xu W, Wang Z, Luo F, Wang Q, Chen H, et al: FGFR3 deficiency causes multiple chondroma-like lesions by upregulating hedgehog signaling. PLoS Genet. 11:e10052142015. View Article : Google Scholar : PubMed/NCBI

9 

Amano K, Densmore M, Fan Y and Lanske B: Ihh and PTH1R signaling in limb mesenchyme is required for proper segmentation and subsequent formation and growth of digit bones. Bone. 83:256–266. 2016. View Article : Google Scholar : PubMed/NCBI

10 

Bechtold TE, Saunders C, Decker RS, Um HB, Cottingham N, Salhab I, Kurio N, Billings PC, Pacifici M, Nah HD and Koyama E: Osteophyte formation and matrix mineralization in a TMJ osteoarthritis mouse model are associated with ectopic hedgehog signaling. Matrix Biol 52–54. 1–354. 2016.

11 

Breidenbach AP, Aschbacher-Smith L, Lu Y, Dyment NA, Liu CF, Liu H, Wylie C, Rao M, Shearn JT, Rowe DW, et al: Ablating hedgehog signaling in tenocytes during development impairs biomechanics and matrix organization of the adult murine patellar tendon enthesis. J Orthop Res. 33:1142–1151. 2015. View Article : Google Scholar : PubMed/NCBI

12 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

13 

Orimo H: The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nippon Med Sch. 77:4–12. 2010. View Article : Google Scholar : PubMed/NCBI

14 

Fujisawa R and Tamura M: Acidic bone matrix proteins and their roles in calcification. Front Biosci (Landmark Ed). 17:1891–1903. 2012. View Article : Google Scholar : PubMed/NCBI

15 

Chen X, Macica CM, Nasiri A and Broadus AE: Regulation of articular chondrocyte proliferation and differentiation by indian hedgehog and parathyroid hormone-related protein in mice. Arthritis Rheum. 58:3788–3797. 2008. View Article : Google Scholar : PubMed/NCBI

16 

Maeda Y, Nakamura E, Nguyen MT, Suva LJ, Swain FL, Razzaque MS, Mackem S and Lanske B: Indian hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone. Proc Natl Acad Sci USA. 104:pp. 6382–6387. 2007; View Article : Google Scholar : PubMed/NCBI

17 

Xing W, Cheng S, Wergedal J and Mohan S: Epiphyseal chondrocyte secondary ossification centers require thyroid hormone activation of Indian hedgehog and osterix signaling. J Bone Miner Res. 29:2262–2275. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Gualeni B, Facchini M, De Leonardis F, Tenni R, Cetta G, Viola M, Passi A, Superti-Furga A, Forlino A and Rossi A: Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling. Matrix Biol. 29:453–460. 2010. View Article : Google Scholar : PubMed/NCBI

19 

Sugita D, Yayama T, Uchida K, Kokubo Y, Nakajima H, Yamagishi A, Takeura N and Baba H: Indian hedgehog signaling promotes chondrocyte differentiation in enchondral ossification in human cervical ossification of the posterior longitudinal ligament. Spine (Phila Pa 1976). 38:E1388–E1396. 2013. View Article : Google Scholar : PubMed/NCBI

20 

Kobayashi T, Chung UI, Schipani E, Starbuck M, Karsenty G, Katagiri T, Goad DL, Lanske B and Kronenberg HM: PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. Development. 129:2977–2986. 2002.PubMed/NCBI

21 

Zhou J, Wei X and Wei L: Indian hedgehog, a critical modulator in osteoarthritis, could be a potential therapeutic target for attenuating cartilage degeneration disease. Connect Tissue Res. 55:257–261. 2014. View Article : Google Scholar : PubMed/NCBI

22 

Mak KK, Kronenberg HM, Chuang PT, Mackem S and Yang Y: Indian hedgehog signals independently of PTHrP to promote chondrocyte hypertrophy. Development. 135:1947–1956. 2008. View Article : Google Scholar : PubMed/NCBI

23 

Brechbiel JL, Ng JM and Curran T: PTHrP treatment fails to rescue bone defects caused by hedgehog pathway inhibition in young mice. Toxicol Pathol. 39:478–485. 2011. View Article : Google Scholar : PubMed/NCBI

24 

Minina E, Wenzel HM, Kreschel C, Karp S, Gaffield W, McMahon AP and Vortkamp A: BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development. 128:4523–4534. 2001.PubMed/NCBI

25 

Kronenberg HM: PTHrP and skeletal development. Ann N Y Acad Sci. 1068:1–13. 2006. View Article : Google Scholar : PubMed/NCBI

26 

Tu X, Joeng KS and Long F: Indian hedgehog requires additional effectors besides Runx2 to induce osteoblast differentiation. Dev Biol. 362:76–82. 2012. View Article : Google Scholar : PubMed/NCBI

27 

Studer D, Millan C, Öztürk E, Maniura-Weber K and Zenobi-Wong M: Molecular and biophysical mechanisms regulating hypertrophic differentiation in chondrocytes and mesenchymal stem cells. Eur Cell Mater. 24:118–135. 2012. View Article : Google Scholar : PubMed/NCBI

28 

Kim KO, Sampson ER, Maynard RD, O'Keefe RJ, Chen D, Drissi H, Rosier RN, Hilton MJ and Zuscik MJ: Ski inhibits TGF-β/phospho-Smad3 signaling and accelerates hypertrophic differentiation in chondrocytes. J Cell Biochem. 113:2156–2166. 2012. View Article : Google Scholar : PubMed/NCBI

29 

Kang JS, Alliston T, Delston R and Derynck R: Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J. 24:2543–2555. 2005. View Article : Google Scholar : PubMed/NCBI

30 

Shimoyama A, Wada M, Ikeda F, Hata K, Matsubara T, Nifuji A, Noda M, Amano K, Yamaguchi A, Nishimura R and Yoneda T: Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol Biol Cell. 18:2411–2418. 2007. View Article : Google Scholar : PubMed/NCBI

31 

Amano K, Densmore M, Nishimura R and Lanske B: Indian hedgehog signaling regulates transcription and expression of collagen type X via Runx2/Smads interactions. J Biol Chem. 289:24898–24910. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Deng A, Zhang H, Hu M, Liu S, Wang Y, Gao Q and Guo C: The inhibitory roles of Ihh downregulation on chondrocyte growth and differentiation Expression of Concern in /10.3892/etm.2025.12946. Exp Ther Med 15: 789-794, 2018.
APA
Deng, A., Zhang, H., Hu, M., Liu, S., Wang, Y., Gao, Q., & Guo, C. (2018). The inhibitory roles of Ihh downregulation on chondrocyte growth and differentiation Expression of Concern in /10.3892/etm.2025.12946. Experimental and Therapeutic Medicine, 15, 789-794. https://doi.org/10.3892/etm.2017.5458
MLA
Deng, A., Zhang, H., Hu, M., Liu, S., Wang, Y., Gao, Q., Guo, C."The inhibitory roles of Ihh downregulation on chondrocyte growth and differentiation Expression of Concern in /10.3892/etm.2025.12946". Experimental and Therapeutic Medicine 15.1 (2018): 789-794.
Chicago
Deng, A., Zhang, H., Hu, M., Liu, S., Wang, Y., Gao, Q., Guo, C."The inhibitory roles of Ihh downregulation on chondrocyte growth and differentiation Expression of Concern in /10.3892/etm.2025.12946". Experimental and Therapeutic Medicine 15, no. 1 (2018): 789-794. https://doi.org/10.3892/etm.2017.5458
Copy and paste a formatted citation
x
Spandidos Publications style
Deng A, Zhang H, Hu M, Liu S, Wang Y, Gao Q and Guo C: The inhibitory roles of Ihh downregulation on chondrocyte growth and differentiation Expression of Concern in /10.3892/etm.2025.12946. Exp Ther Med 15: 789-794, 2018.
APA
Deng, A., Zhang, H., Hu, M., Liu, S., Wang, Y., Gao, Q., & Guo, C. (2018). The inhibitory roles of Ihh downregulation on chondrocyte growth and differentiation Expression of Concern in /10.3892/etm.2025.12946. Experimental and Therapeutic Medicine, 15, 789-794. https://doi.org/10.3892/etm.2017.5458
MLA
Deng, A., Zhang, H., Hu, M., Liu, S., Wang, Y., Gao, Q., Guo, C."The inhibitory roles of Ihh downregulation on chondrocyte growth and differentiation Expression of Concern in /10.3892/etm.2025.12946". Experimental and Therapeutic Medicine 15.1 (2018): 789-794.
Chicago
Deng, A., Zhang, H., Hu, M., Liu, S., Wang, Y., Gao, Q., Guo, C."The inhibitory roles of Ihh downregulation on chondrocyte growth and differentiation Expression of Concern in /10.3892/etm.2025.12946". Experimental and Therapeutic Medicine 15, no. 1 (2018): 789-794. https://doi.org/10.3892/etm.2017.5458
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team